Novel antifungal agents: a patent review (2013 - present)

CD101: a novel long-acting echinocandin

(2016) Yanan Zhao et al.   CELLULAR MICROBIOLOGY

Antifungal drugs combinations: a patent review 2000-2015

(2016) Laura A. Svetaz et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

CD101, a novel echinocandin with exceptional stability properties and enhanced aqueous solubility

(2016) B Radha Krishnan et al.   JOURNAL OF ANTIBIOTICS

Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, againstCandidaandAspergillusspp., including echinocandin- and azole-resistant isolates

(2016) Michael A. Pfaller et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis

(2016) Francisco M Marty et al.   LANCET INFECTIOUS DISEASES

Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms

(2015) Dominique Sanglard et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

How to bolster the antifungal pipeline

(2015) D. W. Denning et al.   SCIENCE

Pharmacodynamic Target Evaluation of a Novel Oral Glucan Synthase Inhibitor, SCY-078 (MK-3118), Using anIn VivoMurine Invasive Candidiasis Model

(2014) Alexander J. Lepak et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Novel antifungal agents: a patent review (2011 – present)

(2014) María Victoria Castelli et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Antifungal drug discovery: the process and outcomes

(2014) Richard Calderone et al.   Future Microbiology

Echinocandins: Are They All The Same?

(2014) PK Mukherjee et al.   JOURNAL OF CHEMOTHERAPY

Amphotericin forms an extramembranous and fungicidal sterol sponge

(2014) Thomas M Anderson et al.   Nature Chemical Biology

Enfumafungin Derivative MK-3118 Shows IncreasedIn VitroPotency against Clinical Echinocandin-Resistant Candida Species and Aspergillus Species Isolates

(2013) Cristina Jiménez-Ortigosa et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

(2013) Barbara D. Alexander et al.   CLINICAL INFECTIOUS DISEASES

Activity of MK-3118, a new oral glucan synthase inhibitor, tested against Candida spp. by two international methods (CLSI and EUCAST)

(2012) M. A. Pfaller et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Amphotericin primarily kills yeast by simply binding ergosterol

(2012) K. C. Gray et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Hidden Killers: Human Fungal Infections

(2012) G. D. Brown et al.   Science Translational Medicine

Invasive Mycoses: Strategies for Effective Management

(2011) Dimitrios P. Kontoyiannis   AMERICAN JOURNAL OF MEDICINE

New Lead Structures in Antifungal Drug Discovery

(2011) Chunquan Sheng et al.   CURRENT MEDICINAL CHEMISTRY

Novel small molecules for the treatment of infections caused byCandida albicans: a patent review (2002 – 2010)

(2011) Chiara Calugi et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Antimicrobial peptides: General overview and clinical implications in human health and disease

(2010) Eduardo Guaní-Guerra et al.   CLINICAL IMMUNOLOGY

Factors Associated with Mortality in Transplant Patients with Invasive Aspergillosis

(2010) John W. Baddley et al.   CLINICAL INFECTIOUS DISEASES

Management of invasive fungal infections: a role for polyenes

(2010) P. Chandrasekar   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

An insight into the antifungal pipeline: selected new molecules and beyond

(2010) Luis Ostrosky-Zeichner et al.   NATURE REVIEWS DRUG DISCOVERY

Burkholdines 1097 and 1229, Potent Antifungal Peptides fromBurkholderia ambifaria2.2N

(2010) Kamilia A. Tawfik et al.   ORGANIC LETTERS

Therapy for fungal diseases: opportunities and priorities

(2010) David W. Denning et al.   TRENDS IN MICROBIOLOGY

Echinocandins: The Newest Class of Antifungals

(2009) Allana J Sucher et al.   ANNALS OF PHARMACOTHERAPY

Activity of Posaconazole and Other Antifungal Agents against Mucorales Strains Identified by Sequencing of Internal Transcribed Spacers

(2009) A. Alastruey-Izquierdo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Amphotericin B and Its New Derivatives – Mode of Action

(2009) M. Baginski et al.   CURRENT DRUG METABOLISM

Mecanismos de resistencia a los antifúngicos: levaduras y hongos filamentosos

(2009) Ana Espinel-Ingroff   REVISTA IBEROAMERICANA DE MICOLOGIA

Changing epidemiology of systemic fungal infections

(2008) M. Richardson et al.   CLINICAL MICROBIOLOGY AND INFECTION

Update on the epidemiology and diagnosis of invasive fungal infection

(2008) Manuel Cuenca-Estrella et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Resistance to Antifungal Agents: Mechanisms and Clinical Impact

(2007) Z. A. Kanafani et al.   CLINICAL INFECTIOUS DISEASES